The energy efficiency services provider has received funding in a CBRE-led round backed by corporate VC units Engie New Ventures and GXP Investments.
Author: Robert Lavine
Zimplistic whips up $30m
EDBI and Credence Partners co-led the Robert Bosch-backed flatbread appliance maker’s series C round as it expands into new markets.
Cohesity courts SoftBank for $150m round
SoftBank Vision Fund is in line to lead the enterprise data storage software provider’s latest round at a $1bn+ valuation.
100Credit charges to $159m series C
The Union Mobile-backed loan services and technology provider has raised money that will support hiring and research and development.
KDDI and Global Brain connect for $187m fund
The telecommunications company has partnered venture firm Global Brain for a fund that will invest in VC funds targeting 5G-relevant companies.
New Leshi Smart Home gets $477m housewarming gift
Sunac, Tencent, Suning and JD.com reportedly supplied $318m for the smart TV maker, an affiliate of LeEco, the rest coming in convertible debt.
Intel Capital triggers Trigence’s series C round
Audio technology developer Trigence took its total funding to more than $20m with an Intel-backed round featuring Supreme Electronics.
BBVA Compass to direct more startups
BBVA’s US subsidiary will admit 35 startups to the BBVA Momentum accelerator this year following a successful first year in 2017.
Vineti processes series B capital
Founding investor GE Ventures participated in a $33.5m series B round that boosted the gene therapy platform’s total funding to more than $47m.
Honest Buildings hikes series B to $25m
The construction project management software developer received $3.5m from QuadReal and Altus Group and has raised $43m altogether.
Barclays banks on corporate venturing
The financial services firm has set up a strategic investment unit that will target areas such as artificial intelligence, distributed ledger and smart contract technology.
BBVA sends $50m to Sinovation Ventures
The bank has put up $50m for the China-based venture firm’s latest fund, which will invest $500m in AI-focused companies.
Evelo reveals $100m IPO filing
The gut-based cancer and inflammatory disease drug developer has raised almost $170m from investors including Celgene, GV and Mayo Clinic.
Turo turns up series D to $104m
Sumitomo and American Express Ventures added $12m to a round already featuring Daimler, SK Holdings and Liberty Mutual Strategic Ventures.